Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2007
11/27/2007US7300659 Comprising an enterohemorragic Escherichia coli (EHEC) cell culture supernatant and an immunological adjuvant
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/27/2007CA2167274C Inactivated respiratory syncytial viral vaccines
11/26/2007CA2580982A1 Compositions and methods for the cure of hiv/aids
11/22/2007WO2007134327A2 Neutralizing antibodies to influenza viruses
11/22/2007WO2007134245A2 Elastin-like polymer delivery vehicles
11/22/2007WO2007134055A1 Antibacterial extracellular polysaccharide solvating system
11/22/2007WO2007133865A2 Hcv/hiv inhibitors an their uses
11/22/2007WO2007133803A2 Treatment of mycobacterial infections
11/22/2007WO2007133781A2 Furanone-initiated polymers
11/22/2007WO2007133261A1 Mucosal formulation
11/22/2007WO2007133153A1 Improved antimicrobial peptides
11/22/2007WO2007132893A1 Suppressor of expression of mcp-1, and ameliorating agent for inflammatory disease, pharmaceutical, supplement, food, beverage or food additive using the suppressor
11/22/2007WO2007132882A1 Pharmaceutical composition for treating or preventing hcv infection
11/22/2007WO2007132846A1 Compound having acidic group which may be protected, and use thereof
11/22/2007WO2007132825A1 Pharmaceutical agent
11/22/2007WO2007132537A1 Novel k04-0144 substances and process for production thereof
11/22/2007WO2007132512A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007WO2007132234A1 Pharmaceutical compositions comprising 5-aminolevulinic acid
11/22/2007WO2007131966A1 Macrocyclic compounds as antiviral agents
11/22/2007WO2007131591A1 Manufacture and use of an antiviral chemotherapeutic substance which changes the metabolism of a host cell into a state in which the replication of viruses in the cell is blocked
11/22/2007WO2007131363A1 Monoclonal antibodies to anthrax protective antigen
11/22/2007WO2007131350A1 Inhibitors of human immunodeficiency virus replication
11/22/2007WO2007131253A2 Use of combination preparations comprising antifungal agents
11/22/2007WO2007120595A3 Amines for the treatment of hcv
11/22/2007WO2007107161A8 Lipid based drug delivery systems comprising phospholipase a2 degradable lipids that perform an intramolecular cyclization reaction upon hydrolysis
11/22/2007WO2007106317A3 Pharmaceutical combinations of hcv-protease and -ires inhibitors
11/22/2007WO2007104932A3 Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof
11/22/2007WO2007100765A3 Lysozyme-modified probiotic components and uses thereof
11/22/2007WO2007098247A3 Substituted taraxastanes useful for treating viral infections
11/22/2007WO2007086995A3 Methylene blue therapy of avian influenza
11/22/2007WO2006130532A3 Treatment of liver diseases in which iron plays a role in pathogenesis
11/22/2007WO2006129158A3 3 - indazolyl - isoxazoline derivatives as inhibitors of phosphodiesterase type - i
11/22/2007WO2006083622A3 Control of enterohemorrhagic e. coli in farm animal drinking water
11/22/2007US20070270499 Use for 2-amino-2-propane-1, 3-diols
11/22/2007US20070270484 3'-N-Substituted-3-O-Substituted Erythronolide a Derivatives
11/22/2007US20070270476 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
11/22/2007US20070270447 Consists of polyurethane and 5-fluorouracil; inhibits or reduces incidence of infection
11/22/2007US20070270418 Inhibitors of P38 and Methods of Using the Same
11/22/2007US20070270417 Antibacterial Agents
11/22/2007US20070270407 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
11/22/2007US20070270404 Tuberculosis treatment using pleuromutilin derivatives
11/22/2007US20070270392 Use of a Cyclopentenone Prostaglandin for Delaying the Onset and/or Preventing the Continuation of Labour
11/22/2007US20070270383 Phosphate derivatives of ritonavir or lopinavir; increased solubility; provide good oral absorption from formulations with higher drug load per unit dosage
11/22/2007US20070270377 Oral Flora-Improving Agent, Antibacterial Agent and Growth Promoter
11/22/2007US20070270370 Novel bicyclonucleoside analogues
11/22/2007US20070270363 Modulation of telomere length by oligonucleotides having a G-core sequence
11/22/2007US20070270359 Nucleic Acid-Based Compounds and Methods of Use Thereof
11/22/2007US20070270357 Bifunctional Macrolide Heterocyclic Compounds and Methods of Making and Using the Same
11/22/2007US20070270356 Substituted 9A-N-[N'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl] and 9A-N-[N'(B-Cyanoethyl)-N'-(Benzenesulfonyl)Carbamoyl-Y-Aminopropyl]Derivatives of 9-Deoxo-9-Dihydro-9A-Aza-9A-Homoerithomycin A
11/22/2007US20070270351 Methods and Reagents for Regulation of Cellular Responses in Biological Systems
11/22/2007US20070270349 Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
11/22/2007US20070270334 Polypeptide-dimers for use in treatment and prevention of infection, bone, blood, eating, tumor, autoimmune and inflammatory disorders
11/22/2007US20070270329 Derived from human glioma cells exhibiting monocyte chemotactic activity at a concentration of 1 nM, and exhibiting an estimated molecular mass of 8,400 daltons.
11/22/2007US20070269856 Viral Purification Methods
11/22/2007US20070269536 Purified bilberry extract containing a mixture of glycosides of delphinidin, cyanidin, petunidin, peonidin, and malvidin; no added bisulfite ions; nutraceuticals and pharmaceuticals
11/22/2007US20070269513 Liver selective drug therapy
11/22/2007US20070269464 Epitope synchronization in antigen presenting cells
11/22/2007US20070269462 Novel exoenzyme toxin of Aeromonas salmonicida, and uses therefor
11/22/2007US20070269460 Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
11/22/2007US20070269458 Vaccines Against Japanese Encephalitis Virus and West Nile Virus
11/22/2007US20070269456 DNA-based plasmid formulations and vaccines and prophylactics containing the same
11/22/2007US20070269450 Biologically active peptides
11/22/2007US20070269449 Fc Fusion Proteins
11/22/2007US20070269445 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
11/22/2007US20070269420 Compounds, Compositions and Methods for Treatment and Prophylaxis of Hepatitis C Viral Infections and Associated Diseases
11/22/2007US20070269414 Method for Producing Gene Transferred Denritic Cells
11/22/2007US20070269408 GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT
11/22/2007US20070269393 Topical anesthetic formulation
11/22/2007US20070269376 Method for Determining Dosage for an Oral Killed Vaccine
11/22/2007DE102006023394A1 Herstellung und Verwendung eines antiviralen Chemotherapeutikums welches eine Wirtszelle dahingehend beeinflusst, dass die Replikation von Viren in der Zelle blockiert wird Preparation and Use of an antiviral chemotherapeutic agent which affects a host cell to the effect that the replication of viruses in the cell is blocked
11/22/2007DE102006023337A1 Triazolderivate II Triazole derivatives II
11/22/2007DE102006023336A1 1,5-Diphenyl-pyrazole II 1,5-diphenyl-pyrazoles II
11/22/2007DE102006023242A1 5-Iodtetrazole zur Verwendung als Antimykotika 5-iodotetrazoles for use as antifungal agents
11/22/2007CA2652452A1 Neutralizing antibodies to influenza viruses
11/22/2007CA2652333A1 Pharmaceutical composition for treating or preventing hcv infection
11/22/2007CA2652219A1 Macrocyclic compounds as antiviral agents
11/22/2007CA2652103A1 Anthrax vaccine
11/22/2007CA2651990A1 Improved antimicrobial peptides
11/22/2007CA2651726A1 Use of combination preparations, comprising antimycotics
11/22/2007CA2651646A1 Antibacterial extracellular polysaccharide solvating system comprising a metal ion sequestering agent
11/22/2007CA2651597A1 Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease
11/22/2007CA2650798A1 Inhibitors of human immunodeficiency virus replication
11/22/2007CA2643680A1 Hcv/hiv inhibitors and their uses
11/22/2007CA2633439A1 Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
11/21/2007EP1857554A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
11/21/2007EP1857464A2 Chlamydia antigens
11/21/2007EP1857460A2 New metal complexes, method of preparing them and therapeutic uses for them
11/21/2007EP1857453A1 Fluoroalkylpyrrolidine derivative
11/21/2007EP1857442A2 Novel antimycobacterial compounds
11/21/2007EP1857122A2 Pharmaceutical compound, containing a stabilised mRNA which is optimised for translation in its coded areas
11/21/2007EP1857115A2 Using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells
11/21/2007EP1857113A2 Method and materials for treating asthma
11/21/2007EP1857110A2 Hormone replacement therapy
11/21/2007EP1857108A1 Preventive or therapeutic agent for herpesvirus-related disease
11/21/2007EP1856155A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor
11/21/2007EP1856125A1 Protease inhibitor precursor synthesis
11/21/2007EP1856103A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
11/21/2007EP1856066A1 Anti-cancer and anti-microbial oxazolidinones and analogues
1 ... 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 ... 1798